Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014 (2014), Article ID 642058, 8 pages
Research Article

In Vivo Lipid Regulation Mechanism of Polygoni Multiflori Radix in High-Fat Diet Fed Rats

Yunnan University of Traditional Chinese Medicine, Kunming, Yunnan 650500, China

Received 6 January 2014; Revised 12 February 2014; Accepted 12 February 2014; Published 30 April 2014

Academic Editor: Kashmira Nanji

Copyright © 2014 Pei Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Marchesini, M. Brizi, G. Blanchi et al., “Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, 2001. View at Google Scholar · View at Scopus
  2. G. Marchesini, E. Bugianesi, G. Forlani et al., “Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome,” Hepatology, vol. 37, no. 4, pp. 917–923, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. McCullough and J. M. D. Arthur, “Update on nonalcoholic fatty liver disease,” Journal of Clinical Gastroenterology, vol. 34, no. 3, pp. 255–262, 2002. View at Publisher · View at Google Scholar
  4. G. C. Farrell, “Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?” Journal of Gastroenterology and Hepatology, vol. 18, no. 2, pp. 124–138, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. C. E. Ruhl and J. E. Everhart, “Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States,” Gastroenterology, vol. 124, no. 7, pp. 1821–1829, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. Schwimmer, C. Behling, R. Newberry et al., “The histological features of pediatric nonalcoholic fatty liver disease(NAFLD),” Hepatology, vol. 36, p. 412, 2002. View at Google Scholar
  7. G. Musso, R. Gambino, and M. Cassader, “Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease(NAFLD),” Progress in Lipid Research, vol. 48, no. 1, pp. 1–26, 2009. View at Publisher · View at Google Scholar
  8. Y. Li, C. H. Gu, and W. Zhang, “The research progress of the pathogenesis of non-alcoholic fatty liver disease,” Chinese Journal of Coal Industry Medicine, vol. 10, pp. 1648–1650, 2009. View at Google Scholar
  9. Commission of Chinese Pharmacopoeia, Pharmacopoeia of the People's Republic of China, vol. 1, China Medico-Pharmaceutical Science & Technology Publishing House, Beijing, China, 2010.
  10. M. J. Wang, R. H. Zhao, W. G. Wang et al., “Lipid regulation effects of Polygoni Multiflori Radix, its processed products and its major substances on steatosis human liver cell line L02,” Journal of Ethnopharmacology, vol. 139, no. 1, pp. 287–2293, 2012. View at Publisher · View at Google Scholar
  11. N. Li, Z. Chen, X. J. Mao et al., “Effects of lipid regulation using raw and processed Polygoni Multiflori Radix in rats fed a high-fat diet,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 329171, 10 pages, 2012. View at Publisher · View at Google Scholar
  12. G. Ji, X. Zhao, L. Leng, P. Liu, and Z. Jiang, “Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats,” Lipids in Health and Disease, vol. 10, article 23, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Juree, N. Kasem, B. William et al., “Induction of human cholesterol 7a-hydroxylase in HepG2 cells by 2, 4, 6 -trihydroxyacetophenone,” European Journal of Pharmacology, vol. 515, no. 1–3, pp. 43–46, 2005. View at Publisher · View at Google Scholar
  14. Y. Wang, J. L. Deng, Z. C. Zuo et al., “Effect of INS and GLP on abundance of DGAT2 mRNA in vitri culture bovine hepatocyte cells,” Chinese Journal of Veterinary Science, vol. 32, no. 11, pp. 1716–1719, 2012. View at Google Scholar
  15. C. Chatterjee and L. Daniel, “Hepatic lipase, high density lipoproteins, and hypertriglyceridemia,” The American Journal of Pathology, vol. 178, no. 4, pp. 1429–1433, 2011. View at Publisher · View at Google Scholar
  16. X. S. Wang, G. Y. Xie, X. L. Shi et al., “The effect of different kinds of Chinese herb medicine such as Radix Polygoni Multiflori on blood biochemical indexes in rats of fatty liver,” Journal of Anhui Traditional Chinese Medical College, vol. 5, pp. 39–40, 2006. View at Google Scholar
  17. W. Fang, Y. W. Qin, L. Y. Wang et al., “The protecting effect of PMTG on the atherosclerotic lesion formation,” Chinese Journal of Drug Application and Monitoring, vol. 1, pp. 48–51, 2005. View at Google Scholar
  18. W. X. Gao, Y. J. Hu, and L. C. Fu, “Lipid regulation effect of TSG of Polygonum Multiflorum Radix,” China Journal of Chinese Material Medica, vol. 4, pp. 323–326, 2007. View at Google Scholar
  19. X. Han, C. A. Wu, W. Wang et al., “Lipid regulation mechanism of TSG of Polygonum Multiflorum Radix,” Chinese Archives of Traditional Chinese Medicine, vol. 8, pp. 1687–1689, 2008. View at Google Scholar
  20. J. G. Fan and Z. J. Xu, “Discuss treatment measures of non-alcoholic steatohepatitis from the pathogenesis,” Modern Medicine & Health, vol. 20, no. 2, pp. 75–76, 2004. View at Google Scholar
  21. J. C. Cohen, J. D. Horton, and H. H. Hobbs, “Human fatty liver disease: old questions and new insights,” Science, vol. 332, no. 6037, pp. 1519–1523, 2011. View at Publisher · View at Google Scholar
  22. A. P. Lin and J. Yu, “Research on diabetic patients with non-alcoholic fatty liver,” Progress in Modern Biomedicine, vol. 10, no. 19, pp. 3762–3764, 2010. View at Google Scholar
  23. H. Li, L. Xue, Y. Song et al., “The effect of insulin on triglycerides synthesis and lipolysis of mice primary hepatocytes,” Progress in Modern Biomedicine, vol. 3, pp. 401–404, 2013. View at Google Scholar